It looks like you're using an Ad Blocker.

Please white-list or disable in your ad-blocking tool.

Thank you.


Some features of ATS will be disabled while you continue to use an ad-blocker.


Vaccines Become Hot Property For Big Pharma

page: 1

log in


posted on Sep, 30 2009 @ 09:22 PM

NPR Health Blog
September 29, 2009
By Scott Hensley

After years of beating a retreat from making vaccines, the world's biggest drug companies are piling back in.

Vaccines are giving the drug business a shot in the arm.

The Wall Street Journal takes a look at three deals Monday that show the business of making vaccines has become hot again. Johnson & Johnson, for instance, agreed to pay $441 million for a stake in Crucell, a Dutch biotech firm, in a deal to collaborate on a single vaccine against all kinds of flu and some other projects.

Many drugmakers turned their backs on the most common vaccines, such as flu shots, after years of low profits and worries about lawsuits. Wyeth gave up making flu vaccine in 2002, after losing money in four of the preceding five years on the business.

The exodus of companies from the flu business left the US dependent on two companies for its supply of flu shots a few years ago. When one of those suppliers ran into problems at its main factory in 2004, the US experienced the worst shortage of flu vaccine in history.

But the big push for swine flu vaccine as well as a slowdown in the traditional business of making drugs has several companies reconsidering their bets. Merck, never abandoned vaccines, but hadn't been selling a flu vaccine. Merck made a deal to market Australian vaccine-maker CSL's seasonal flu vaccine in the US starting next year.

Most of the US companies that stayed in the vaccine business have emphasized high-priced vaccines against serious illnesses, such as Merck's Gardasil, against cervical cancer.

The revival of interest in vaccines isn't exactly philanthropic. "If you have a new vaccine for a new type of meningitis or swine flu, that clearly is a major public-health issue and, therefore, the willingness to pay is going to be greater," said Murray Aitken, a senior vice president at IMS Health told the Journal.

Please visit the link provided for the complete story.

Especially big business for the criminal enterprise Baxter Pharmaceutical, who got caught putting the H1N1 virus IN their vaccines!

[edit on 30-9-2009 by GoldenFleece]

posted on Sep, 30 2009 @ 09:35 PM
the worlds biggest con job is what this all is

how much are the pharma companies making off of each shot from countries around the globe?

They want you to get multiple shots or offer nasal solutions because they make more money with each shot.

H1N1 Vaccine To Cost Countries $2.50 - $20 Per Dose

This is so obviously a scam

remember the last flu that the MSM made a huge deal about, H5N1...
it slowly faded from view once no pandemic was forthcoming but the media sure were in a frenzy when H5n1 was discovered

in our age of super cheap mass production, why is one shot costing at least $2.50? Some running shoes are made for pennies and sell for hundreds of dollars. It probably costs a few cents to produce a "vaccine"
the rest is pure profit

I believe that companies should be limited to an operational size limit and income cap to guarantee that everyone is on the same level playing and has an equal shot at success.

Maybe we should form a committe ourselves and pass these things as law.
Everyone would have jobs, true competitive free markets...just imagine

[edit on 30-9-2009 by warrenb]

posted on Sep, 30 2009 @ 09:46 PM
reply to post by warrenb

Scam is right. Amazingly enough, 60 Minutes devoted a segment to all the neurological damage caused by the Swine Flu vaccine in 1976:

'60 Minutes' Swine Flu Vaccine Damage

Some people never learn.

posted on Sep, 30 2009 @ 10:01 PM
If you ever watch the channel ABC then you will realize just about every other commercial is for a drug. That is one channel you do not want to get medical advice from.

new topics


log in